chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No reaction post vaccination? I only historically had gotten a total of 4 flu vaccines. 24 hours after Moderna I had b/l dorsal foot tingling that I didn?t really pay any mind to, then by the next day it spread to L hand (4th-5th digit) overt weakness and paresthesias and a cool/numb feeling to my R thumb. Similar symptoms to L 5th toe and R great toe. As days progressed it got more diffuse and extended up to mid-calf that was very mild... eventually by day 10 it dissipated, thank god.  To add I also experienced L facial dull pain and the distal portion of my tounge felt like I burnt it (lasted 5 -7 days)
Moderna COVID vaccines received on 1/29/2021 and 2/26/2021 Hospitalized at Hospital on 10/8/2021 for COVID-19 Additional Moderna Booster received on 12/30/2021 after the adverse event
A report was received from a health care professional on 11/24/03 concerning a 60 year old female vaccinee who was inadvertently administered frozen Fluvirin on an unreported date. On an unknown date, the vaccinee inadvertently received Fluvirin, which had been left adjacent to a freezer compartment and was subsequently frozen. The vaccinee will be advised to receive Fluvirin again in 3 weeks time. It was not reported if the vaccinee had experienced any adverse reaction. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
10:16 am - Client complained of blurry vision and chest pressure and increased blood pressure after 15 minutes after receiving the vaccine. Client was evaluated by MD onsite at the Mini POD and EMS. Client was transported by EMS to Hospital. Did a follow up call found out client was only in the Emergency Room and then was discharged with no medication. Advised client to monitor blood pressure and follow up appointment with MD if need to start Blood pressure medications.
Immunizations (below) given on 01/05 at 16:00.  On 01/06 at 21:00, mom noted nickel sized bump described as red, warm, raised and painful to touch.  Red area grow in size gradually.  Pt seen on 01/07/04.  Wheal on left deltoid 9x4in, red, raised, warm and hard and painful to palp.  Area continued with inc.  Mom has placed heat on site 3-4 times since 01/05 at 16:00, taking Motrin every 6 hours.  No fever.  Pt otherwise well.  Pt is recovering now.
Patient states that he had chills, fever, stiffness in neck and lower back that he noticed on 6/28/08 around 7am.
Breast cancer; This case was reported by a consumer via call center representative and described the occurrence of breast cancer in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced breast cancer (serious criteria GSK medically significant). On an unknown date, the outcome of the breast cancer was unknown.   It was unknown if the reporter considered the breast cancer to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient was diagnosed with breast cancer after receiving a dose of Shingrix. The patient enquired if it was safe for her to receive 2nd dose of Shingrix since she was due for it. Till the time of reporting, the patient did not start the therapy for breast cancer.
Information has been received from a nurse referring to an unspecified number of patients of unknown age and gender. On unknown dates these patients received improperly stored ROTATEQ (dose, frequency and lot# were not reported) orally. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Caregiver reported client had red ring and hard lump where injection was given within 24 hours on vaccination.  Site is still red but hard lump has dissipated.
COVID+ 12/17/22.  Vaccination Status - J&J x1, Pfizer x1 Discharge Information: Discharge Provider: MD  Primary Care Provider: DO Procedures to be scheduled by PCP: None  Results/Procedures requiring PCP followup: Follow up left finger celluliits  Admission Date: 12/21/2022 Discharge Date: 12/26/2022  Admitting Diagnoses: COVID-19 Details of Hospital Stay PRESENTING PROBLEM:  Acute respiratory failure with hypoxia (HCC) [J96.01] COVID-19 virus infection [U07.1] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 51 y.o. female  who presents to hospital with difficulty breathing. The patient is known to have history of multiple comorbidities including anxiety, diabetes mellitus type 2, DVT, hypertension, GERD, peptic ulcer disease, peripheral arterial disease, OCD, morbid obesity with body mass index 51, chronic obstructive pulmonary disease, tobacco use, and chronic kidney disease stage 3. in the last 4 days before her presentation, the patient has been complaining of coughing, difficulty breathing, and had fever.  The patient has been using her significant other?s oxygen at her home in the last 2 days before her presentation.  Because of the deterioration of her breathing, EMS was called and the patient was presented to the emergency department for evaluation.  On arrival the patient was hypoxic with oxygen saturation 84% on room air.  She required 2 liters/minute nasal cannula oxygen supplement.  Also the patient was initially tachypneic with respiratory 37 and hypertensive with blood pressure 171/95.  Her initial workup showed   Positive PCR rapid test for COVID 19 but her chest x-ray did not show any acute cardiopulmonary process.  On the physical exam, the patient had diffuse bilateral moderate expiratory wheezing.  The patient has morbid obesity and likely sleep apnea.  When I did my telehealth visit, the patient was initially sleeping and she requires 4 liters/minute nasal cannula oxygen supplement while sleeping.  The patient denies chest pain.  Dexamethasone has already started in the emergency department.     Patient was treated with dexamethasone and remdesivir.  Her oxygen was gradually weaned.  She was found to have a small cut on the inner surface of her left index finger.  This became swollen and tender with some erythema.  X-ray did not show any acute findings.  She was started on cefazolin and it was felt she could safely be discharged on a course of Keflex to complete 7 days of treatment.  She completed a course of remdesivir and was able to be weaned to room air.  It was felt that she could be safely discharged home for outpatient follow-up care.
I was given the vaccine before being released from hospital within few hours I start having pain in my arm and it gradually turned severe within hours of receiving vaccine, couldn't use my arm for about two weeks, it caused paralysis, I have been put on many medications and I am currently on gabapentin to control my nerve pain.
pt recvd vax & exp chills & fever 101; 2 days p/vax exp sor throat & sweatiness; pt did not receive treatmnet; reporter indicated that pt recovered;
PATIENT REPORTED NORMAL ARM DISCOMFORT IMMEDIATELY AFTER INJECTION THEN 2 WEEKS LATER SHE SAID SHE WAS HAVING AN MRI AND WHEN ASKED TO LIFT HER ARMS ABOVER HER HEAD THAT SHE HAD A DIFFICULT TIME DOING SO AND THAT IT CAUSED SOME DISCOMFORT. SHE WANTED TO WAIT A LITTLE LONGER TO SEE IF IT WOULD RESOLVE, BUT AS OF 2/13/18 THE DISCOMFORT IS STILL NOTICABLE SOMETIMES AND SHE THOUGHT SHE BETTER LET US KNOW.
This spontaneous report as received from a pharmacist refers to a patient in her "forties" with allergic. The patient was vaccinated with ZOSTAVAX on DEC-2011. No adverse effect reported. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient experienced 40s received ZOSTAVAX. No treatment information was reported. The outcome of 40s received ZOSTAVAX is unknown. The pharmacist also stated that the patient told her that she "couldn't tolerate VALTREX", and was "very allergic to it". No other information is available at this time. Additional information is expected.
SEIZURE; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Company is unable to perform follow-up to confirm batch/lot number. No concomitant medications were reported.  On an unspecified date, after administration of vaccine the patient started having a seizure and ended up going to hospital (date unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of seizure was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0:  20210333412 - JANSSEN COVID-19 VACCINE Ad26.COV2.S - Seizure. This event is considered Unassessable. The event has a compatible/suggestive temporal relationship, is unlabelled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Fever of101.0 for approximately 24 hours with muscle and joint discomfort no temperature on 1/24/2021 feeling better today
I got a case of shingles: blistering below my waist, on my abdomen, and top of my buttock area.; This spontaneous case was reported by a physician and describes the occurrence of HERPES ZOSTER (I got a case of shingles: blistering below my waist, on my abdomen, and top of my buttock area.) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Mar-2021, the patient experienced HERPES ZOSTER (I got a case of shingles: blistering below my waist, on my abdomen, and top of my buttock area.). The patient was treated with VALACYCLOVIR [VALACICLOVIR] for Shingles, at an unspecified dose and frequency and PREGABALIN (LYRICA) for Pain, at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (I got a case of shingles: blistering below my waist, on my abdomen, and top of my buttock area.) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Action taken with mRNA-1273 in response to the event was not applicable.
Fever up to 102; body aches; hip and back joint pain; chills; fatigue; This is a spontaneous report from a contactable other healthcare professional (patient). A 37-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (lot number: EH9899) on 18Dec2020 17:00 (first dose) then (lot number: EC1284) on 05Jan2021 07:45 (second dose); both intramuscular on the left arm at a single dose for COVID-19 immunization. The patient's medical history included anxiety and depression. The patient was not pregnant at the time of vaccination. Concomitant medication included citalopram and multivitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took amoxicillin and experienced allergies to amoxicillin. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. On 05Jan2021 17:30, the patient experienced fever up to 102, body aches, hip and back joint pain, chills, and fatigue. Outcome of the events was recovering. The events were considered non-serious by the reporter.
2 wks p/vax pt devel hepatitis which required liver biopsy which revealed autoimmune chronic active hepatitis which has since required Prednisone & now Imuran & other meds & side efforts;
12/13/22 presents to ED for "cough". PMHx of "HTN, HLD, seizure disorder on keppra, breast Ca"
My whole right arm went numb. I have not had treatment. I talked to my neurologist about it and she told me to keep an eye on it. Eventually it went away.
This spontaneous prospective pregnancy report was received from the patient's husband and refers to her wife a female patient of unknown age. The patient's medical history, concurrent conditions and allergies were not reported. In approximately September 2015 (reported as "no enough one month"), the patient was vaccinated with a dose of (Oka/Merck) VARIVAX, (strength, dose, frequency, route, anatomical location, lot number and expiration date were not reported). Other suspect and concomitant therapies were not reported. Then, in approximately September 2015, the patient became pregnant. The last menstrual period (LMP) and estimated date of delivery (EDD) were not reported. The pregnancy outcome was pending. The reporter wanted to know if there were any effects on the baby. Additional information has been requested.
Within 24 hours of the 2nd dose, I had terrible cramps related to my menstrual cycle at a pain level that I had not experienced since my early 20s. I was able to take ibuprofen to resolve the pain and did not need further medical attention. Pain resolved by the next morning.
5 hrs p/receiving MMR vax pt exp severe nausea, & vomiting, w/fever of 102 for 2 1/2 days; Pt reports no previous allergies; Pt recvd dose in 1965 w/no response & no allergy; Pt is due for 3rd dose;
Day of second shot was fine. The next day injection site was hot, swollen, red. Swelling increased throughout the day. Redness also grew throughout the day. Very painful to the touch. Arm has not gotten better. Also the day after the second shot I was very tired, whole body was achey. Had a low grade fever. Felt nauseous off and on all day. Don?t feel as sick today (2 days after second shot). Although my arm has not gotten better. Tried ibuprofen, Benadryl, ice packs. Lots of fluids and rest. The ice pack would make the rest of my arm cold but where my arm is swollen, it stayed hot and very painful.
Information has been received from a physician concerning a female consumer who on an unspecified date was vaccinated with a single dose of Zostavax.  Subsequently, 2 days after vaccination, the patient developed redness and blisters at the injection site.  The patient called the office.  No treatment was recommended by the physician.  No further information was provided.  There was no product quality complaint involved.  Additional information is not expected.
Information has been received from a registered nurse concerning a female who was vaccinated with Gardasil. Subsequently the patient fainted. This is one of several reports from the same source. Additional information has been requested.
No additional AE; MA reported that one Patients ( name or initials not provided when asked) received  GARDASIL 9 ( lot number 1780878 exp: 12/02/2023) exposed to 55 F for 15 min. Temperature excursion happened on  Sept 7,2022 and patient received it on 12/06/2022.; This spontaneous report was received from  a Medical Assistant regarding a 13-year-old patient of an unknown gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 07-SEP-2022, an improperly stored vaccine of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) underwent a temperature excursion of 55 degrees Fahrenheit (F) for 15 minutes.  On 06-DEC-2022, the patient was vaccinated with the improper stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) lot #1780878, expiration date: 02-DEC-2023, (strength, dosage regimen, anatomical location, and route of administration were not provided) administered as prophylaxis (Product storage error). No adverse events were reported.  This is one of two case received from the same reported. ; Sender's Comments:  US-009507513-2212USA005886:
Flu like symptoms including headache, temperature, body aches, chills, extreme fatigue, sore throat, shakiness, I read that these are common symptoms, but it has been two weeks and the fatigue and pain are not improving.
I had appointment for another issue. Dr. had given me a shot for pneumonia at my visit the previous year and advised I was due for a booster which she gave me on 04/28. 2 or 3 days later a 2 inch red square appeared where the injection had been done. The next day it had become a 5" X 3" oval which was hot and tender. It did eventually go away.
Breakthrough case admission after 4 vaccines Moderna 2/14/21 Lot# 015M20A;  Moderna 3/14/21 Lot# 044A21A;  Moderna 9/15/21 Lot# 005C21A;  Moderna 4/28/22 Lot# 057M21A
SEVERE.PAINFFUL RASH ON BODY. ARMS,LEGS,BACK, STOMACH
PATIENT WAS GIVEN EXPIRED VACCINE.  UNKNOWN OF ANY ADVERSE EVENTS AT THIS TIME
Pain in the right arm, opposite arm from the injection site,  started the day after vaccination. Pain has persisted for many months and is still a dull ache as of today.
Nurse gave Pfizer2023/2024 5-11yo vaccination and a FluQuad (65+yo) vaccination to a 38 year old patient. Nurse pulled vaccines from the incorrect stock and failed to perform rights of drug administration in a rush.  The Clinic Manager found this error during inventory count and immediately notified the Chief Operations Officer and Chief Clinical Officer of the facility.  The patient has not reported any adverse affects.  Patient is being notified by the Chief Medical Officer.  The nurse has been given a verbal warning and reeducation and extra training has been put in place.  Additional signage of  rights of drug administration have been posted in the vaccination area as well as rooms.
Information has been received from a nurse concerning an 8 year old female who on an unknown date, was vaccinated with the second dose of VARIVAX (Merck) (lot# 662572/0045Y) 0.5mL. Subsequently, the patient developed a rash around the injection site and throughout her arm in which she received the injection. Subsequently, the patient recovered from the rash around injection site and throughout her arm. Unspecified medical attention was sought. This is one of several reports from the same source. Additional information has been requested.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On 28-MAR-2014 the patient was vaccinated with an expired MMR II (expiry date 07-MAR-2014, lot number unknown) (dosing regimen and frequency unknown). No concomitant medications were reported. No adverse event was reported. The action taken with the therapy with MMR II was unknown. The outcome of events was unknown. The relatedness of the events to the therapy with MMR II was unknown. No product quality issue was reported. Additional information has been requested.
Information has been received from a physician concerning a child who, in the past, was vaccinated with Varivax. In approximately 2005, within the last year, the patient experienced a minor case of breakthrough chickenpox. Subsequently, the patient fully recovered. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Received his second vaccine in the series on 10/5/2022 and he started to become ill on 10/7/22.  Had nausea and vomiting, "terrible" headache, and fatigue for four days.  Missed work.   States that he felt like he was dying.
I developed vertigo.; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 36 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 08Jan2021 (Lot number: EL1283) at the age of 36 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Allergy: Sulfa" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EL0140), administration date: 19Dec2020, when the patient was 35 years old, for COVID-19 immunization. The following information was reported: VERTIGO (non-serious) with onset Jan2021, outcome "recovered" (2021), described as "I developed vertigo.". Therapeutic measures were not taken as a result of vertigo.  Additional Information: Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  No follow-up attempts are possible. No further information is expected.
Chills; Aches; Ran a fever from 99 -101 degree; Still achy/not feeling well; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration on 20Apr2021 at 16:00 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history included cerebral palsy and some other mental health diagnoses. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lamotrigine (MANUFACTURER UNKNOWN), ethinylestradiol/ levonorgestrel (SEASONALE) and docusate sodium (COLACE); all for unknown indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 30Mar2021 at 16:00 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 04:00, 12 hours after the vaccine, the patient woke up with chills and aches. Ran a fever from 99-101 degree until 19:00 with chills and aches. The patient still felt achy/not felt well through next day. The patient also stayed home from school for two days. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On 23Apr2021, the patient underwent rapid test via nasal swab and the result was negative. Therapeutic measures were taken as a result of the events and included treatment with one extra strength paracetamol (TYLENOL) every few hours. The clinical outcome of the events ran a fever from 99-101 degree was resolved on 21Apr2021 at 19:00; while that of chills, aches and still achy/not feeling well was resolved in Apr2021.  No follow-up attempts are needed. No further information is expected.
This non-serious spontaneous case, initially received from other non-health professional on 13-Nov-2018, concerns a 79-year-old, elderly patient of unspecified gender. It was reported that, the FLUAD (TIV) vaccine underwent temperature excursion for the first time. The vaccine was out for around 48 hours and it reached 11.6 degree Celsius. On 02-Nov-2018, the patient was administered FLUAD (TIV) [batch number: 250802, dose, route of administration, anatomical location and expiry date: not reported] which underwent temperature excursion. At the time of this report, no adverse event was reported. This case 201805532 was crossed linked to original case 201804863 due to same reporter.
Information has been received from a consumer concerning her 60 year old brother, with hypertension and allergy to bee stings, who "a few weeks ago" was vaccinated with a dose of ZOSTAVAX (Merck) (lot #, expire date and route not reported). Concomitant therapy included vitamins (unspecified) and unknown hypertension medications. On an unspecified date the patient experienced a headache that lasted two weeks post vaccination. After those two weeks the patient reported that his jaw would not open, one side of his face was swollen and he had fever. The patient was seen by his physician a few days ago and was put on unknown antibiotic for treatment. At the time of the report, the patient had recovered from headache and was recovering from his jaw did not open, his face was swollen and the fever. Additional information is not expected.